01376nas a2200469   4500000000100000000000100001008004100002653001000043653000900053653002900062653003500091653004700126653003600173653001100209653004200220653001100262653001400273653000900287653001600296653003900312653003600351653002700387653001000414653001900424653003200443100001000475700001700485700001200502700001600514700002600530700001700556700001300573700001500586700002300601700001200624700002100636245018200657250001500839300001200854490000800866020003200874       2022                            d10aAdult10aAged10aBell Palsy/*epidemiology10aCOVID-19/*prevention & control10aCOVID-19 Vaccines/*administration & dosage10aEncephalomyelitis/*epidemiology10aFemale10aGuillain-Barre Syndrome/*epidemiology10aHumans10aIncidence10aMale10aMiddle Aged10aMyelitis, Transverse/*epidemiology10aRoutinely Collected Health Data10aSARS-CoV-2/*immunology10aSpain10aUnited Kingdom10aVaccination/adverse effects1 aX. Li1 aB. Raventós1 aE. Roel1 aA. Pistillo1 aE. Martinez-Hernandez1 aA. Delmestri1 aC. Reyes1 aV. Strauss1 aD. Prieto-Alhambra1 aE. Burn1 aT. Duarte-Salles00aAssociation between covid-19 vaccination, SARS-CoV-2 infection, and risk of immune mediated neurological events: population based cohort and self-controlled case series analysis  a2022/03/18  ae0683730 v376  a0959-8138 (Print)
0959-8138